Julie AUFFRAY, Vanessa BOURGEAUX, Pascal GEORGE, Stéphanie BRIANCON, Claudia GAMA, Julien LEROUDIER, Hassan BENAMEUR, Quentin BOOULAY
Skyepharma has been a specialist in complex oral solid dosage forms for over 25 years, and enjoys a solid reputation for its expertise and agility. Skyepharma differentiates itself by its ability to managecomplex projects: complexity of the active ingredient (highly active, biological, psychotropic, narcotic, etc.), complexity of the formulation (controlled release, combination of different APIs, etc.), complexity in terms of logistics (small batch sizes, personalized medicine, etc.).
We were very proud to have organized our first scientific day, entitled
“Advances in Overcoming Oral Dosage Form Development Challenges”.
The objective of this event was to bring together experts and key industry players to share the latest innovations and strategies in oral dosage form development, with a focus on key topics such as bioavailability, formulation and industrialization. Several partners are associated with this event: Medelpharm, Gattefosse, Seqens & GEA.
A huge thank you! to all our participants, speakers, and partners and for making Skyepharma’s Scientific Symposium 2025 a success! Your insights, engagement, and support were invaluable in shaping this inspiring event. We look forward to continuing this journey of innovation together!